BARK (NYSE:BARK – Get Free Report) had its price objective boosted by stock analysts at Canaccord Genuity Group from $2.00 to $2.50 in a research note issued on Monday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Canaccord Genuity Group’s price objective points to a potential upside of 14.16% from the stock’s current price.
BARK Stock Performance
Shares of NYSE:BARK opened at $2.19 on Monday. BARK has a 52 week low of $0.70 and a 52 week high of $2.25. The company has a quick ratio of 1.49, a current ratio of 2.42 and a debt-to-equity ratio of 0.32. The company has a 50 day moving average price of $1.61 and a two-hundred day moving average price of $1.58.
Insider Activity
In other BARK news, Chairman Matt Meeker bought 34,000 shares of the stock in a transaction dated Monday, November 11th. The stock was purchased at an average cost of $1.52 per share, for a total transaction of $51,680.00. Following the completion of the acquisition, the chairman now owns 10,734,460 shares of the company’s stock, valued at approximately $16,316,379.20. This trade represents a 0.32 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 14.80% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On BARK
About BARK
BARK Inc, a dog-centric company, provides products, services, and content for dogs. It operates in two segments, Direct to Consumer and Commerce. The company serves dogs through monthly subscription services. It is also involved in the design of playstyle-specific toys, satisfying treats, personal meal plans with supplements, and dog-first experiences designed to foster health and happiness of dogs everywhere.
See Also
- Five stocks we like better than BARK
- P/E Ratio Calculation: How to Assess Stocks
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- What is a Low P/E Ratio and What Does it Tell Investors?
- Netflix Is On Track To Hit $1,000 By Christmas
- How to Invest in Biotech Stocks
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for BARK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BARK and related companies with MarketBeat.com's FREE daily email newsletter.